The first Phase 3 results came from the TRIUMPH-4 trial, announced in December
Patients using telehealth platforms experience 2448 hour prescription-to-shipment timelines compared to 36 weeks through traditional insurance pathways, which face pre-authorization denials in 68% of initial requests
It may take some time to find the right combination of diet, herbs, and lifestyle habits that make your journey through menopause as smooth as possible
The FDA has not approved retatrutide and the compound cannot lawfully be used in compounding under U.S
For RCTs, this included assessment of: (1) risk of bias (via Cochrane RoB 2 tool), (2) inconsistency of results across studies, (3) indirectness of evidence, (4) imprecision due to sample size or confidence intervals, and (5) potential publication bias